Cargando…

The public health emergency medical countermeasures enterprise : innovative strategies to enhance products from discovery through approval : workshop summary /

"During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasu...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: Institute of Medicine (U.S.). Forum on Medical and Public Health Preparedness for Catastrophic Events, Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation
Otros Autores: Wizemann, Theresa M., Stroud, Clare, Altevogt, Bruce M.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington : National Academies Press, ©2010.
Colección:The national academies
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBOOKCENTRAL_ocn650558721
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu---unuuu
008 100728s2010 dcua ob 100 0 eng d
010 |a  2012405814 
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d MMU  |d YDXCP  |d IDEBK  |d OCLCQ  |d E7B  |d VPI  |d OCLCQ  |d DKDLA  |d ORU  |d OCLCQ  |d OCLCA  |d OCLCF  |d OCLCO  |d OCLCQ  |d OCLCA  |d NLGGC  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d EBLCP  |d DEBSZ  |d OCLCO  |d DXU  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d OCLCQ  |d AZK  |d OCLCO  |d LOA  |d OCLCA  |d VT2  |d OCLCQ  |d TOA  |d OCLCO  |d AGLDB  |d MOR  |d CCO  |d PIFAG  |d ZCU  |d OCLCO  |d MERUC  |d OCLCO  |d OCLCQ  |d OCLCO  |d NJR  |d OCLCO  |d MERER  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d BUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d CUY  |d KIJ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d STF  |d WRM  |d VNS  |d V5E  |d OCLCQ  |d VTS  |d COCUF  |d NRAMU  |d EZ9  |d OCLCQ  |d ICG  |d OCLCO  |d AU@  |d OCLCO  |d WYU  |d OCLCO  |d OCLCQ  |d LVT  |d S9I  |d TKN  |d OCLCQ  |d DKC  |d OCLCO  |d OCLCQ  |d M8D  |d OCLCO  |d OCL  |d OCLCO  |d OCLCQ  |d OCLCO  |d UKAHL  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d AJS  |d OIP  |d OCLCO  |d TUHNV  |d INARC  |d OCLCO  |d OCL  |d OCLCQ  |d SFB  |d OCL  |d OCLCO  |d OCLCL  |d OCLCQ  |d OCLCL 
016 7 |a 101537597  |2 DNLM 
019 |a 639008311  |a 764541661  |a 768692362  |a 770820997  |a 923281822  |a 961542346  |a 962610764  |a 971068391  |a 1021270925  |a 1028768279  |a 1039222065  |a 1055338726  |a 1061014832  |a 1061048220  |a 1062861080  |a 1119432351  |a 1119455416  |a 1156373935  |a 1204383186  |a 1204390993  |a 1228538545  |a 1235840833  |a 1243599664  |a 1249243188  |a 1280744065 
020 |a 9780309150255  |q (electronic bk.) 
020 |a 0309150256  |q (electronic bk.) 
020 |z 0309150248 
020 |z 9780309150248 
029 1 |a AU@  |b 000051338800 
029 1 |a DEBBG  |b BV043093080 
029 1 |a DEBBG  |b BV044109061 
029 1 |a DEBSZ  |b 421711604 
029 1 |a DEBSZ  |b 452577667 
029 1 |a NZ1  |b 13866174 
035 |a (OCoLC)650558721  |z (OCoLC)639008311  |z (OCoLC)764541661  |z (OCoLC)768692362  |z (OCoLC)770820997  |z (OCoLC)923281822  |z (OCoLC)961542346  |z (OCoLC)962610764  |z (OCoLC)971068391  |z (OCoLC)1021270925  |z (OCoLC)1028768279  |z (OCoLC)1039222065  |z (OCoLC)1055338726  |z (OCoLC)1061014832  |z (OCoLC)1061048220  |z (OCoLC)1062861080  |z (OCoLC)1119432351  |z (OCoLC)1119455416  |z (OCoLC)1156373935  |z (OCoLC)1204383186  |z (OCoLC)1204390993  |z (OCoLC)1228538545  |z (OCoLC)1235840833  |z (OCoLC)1243599664  |z (OCoLC)1249243188  |z (OCoLC)1280744065 
043 |a n-us--- 
050 4 |a RA645.5  |b .P83 2010eb 
060 4 |a WA 295 
072 7 |a POL  |x 020000  |2 bisacsh 
082 0 4 |a 353.9/50973  |2 22 
049 |a UAMI 
245 0 4 |a The public health emergency medical countermeasures enterprise :  |b innovative strategies to enhance products from discovery through approval : workshop summary /  |c Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. 
260 |a Washington :  |b National Academies Press,  |c ©2010. 
300 |a 1 online resource (xiv, 179 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
490 0 |a The national academies 
504 |a Includes bibliographical references. 
505 0 |a Background. The public health perspective on medical countermeasure development, acquisition, and use -- The FDA perspective on the countermeasures enterprise: moving forward -- Government procurement of science -- Partners in a single mission, diverse concerns and challenges. The growing threat of bioweapons -- Gaps and barriers to international collaboration -- Issues for federal agencies engaged in countermeasures development -- Challenges facing the innovative biopharmaceutical industry -- Research infrastructure and resources -- Liability -- End users: challenges for public health and providers -- Examples of successful countermeasures development and deployment. Features of successful government countermeasures efforts -- countermeasures development in industry -- Partnerships and alternative business models. Venture philanthropy and orphan product development models -- Pharmaceutical shared-risk approaches -- Planning for failure -- Open innovation business strategies -- Public-private partnerships -- Independent third-party facilitation of collaboration -- Strategic investor model -- Engaging industry. Incentives: Push vs. Pull -- Incentives not needed?: making a strong business case -- New paradigms, strategies, a nd tactics for enhancing the countermeasures development enterprise. Outsourcing program management -- Government as a strategic partner --Platform technologies -- Revised PHEMCE implementation plan -- Existing regulatory tools and approaches that can be applied to advance countermeasures development. Opportunities for accelerating approval of medical countermeasures: evolving the regulatory framework -- The way forward: themes from the workshop. 
520 |a "During public health emergencies such as pandemic influenza outbreaks or terrorist attacks, effective vaccines, drugs, diagnostics, and other medical countermeasures are essential to protecting national security and the public's well-being. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE--a partnership among federal, state, and local governments; industry; and academia) is at the forefront of the effort to develop and manufacture these countermeasures. However, despite the PHEMCE's many successes, there are still serious challenges to overcome. Government-funded medical research is not always focused on countermeasures for the most serious potential threats, and it is difficult to engage pharmaceutical and biotechnology companies to develop and manufacture medical countermeasures that have a limited commercial market. At the request of the Secretary of the U.S. Department of Health and Human Services and the Assistant Secretary for Preparedness and Response, the IOM held a workshop February 22-24, 2010, to address challenges facing the PHEMCE. Workshop participants discussed federal policies and procedures affecting the research, development, and approval of medical countermeasures and explored opportunities to improve the process and protect Americans' safety and health." 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Emergency management  |z United States  |v Congresses. 
650 0 |a Public health  |z United States  |v Congresses. 
650 0 |a Emergency management  |v Congresses. 
650 0 |a Emergency medical services. 
650 0 |a Medical emergencies. 
650 0 |a Public health. 
650 1 2 |a Disaster Medicine 
650 2 |a Emergency Medical Services 
650 2 |a Program Development 
650 2 2 |a Emergencies 
650 2 2 |a Public Health 
651 2 |a United States 
650 6 |a Santé publique  |z États-Unis  |v Congrès. 
650 6 |a Services des urgences médicales. 
650 6 |a Urgences médicales. 
650 6 |a Santé publique. 
650 7 |a emergency medical centers.  |2 aat 
650 7 |a public health.  |2 aat 
650 7 |a POLITICAL SCIENCE  |x Government  |x State & Provincial.  |2 bisacsh 
650 7 |a Medical emergencies  |2 fast 
650 7 |a Emergency medical services  |2 fast 
650 7 |a Emergency management  |2 fast 
650 7 |a Public health  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
655 0 |a Electronic books. 
655 2 |a Congress 
655 7 |a proceedings (reports)  |2 aat 
655 7 |a Conference papers and proceedings  |2 fast 
655 7 |a Conference papers and proceedings.  |2 lcgft 
655 7 |a Actes de congrès.  |2 rvmgf 
700 1 |a Wizemann, Theresa M. 
700 1 |a Stroud, Clare. 
700 1 |a Altevogt, Bruce M. 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Medical and Public Health Preparedness for Catastrophic Events. 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Drug Discovery, Development, and Translation. 
758 |i has work:  |a The public health emergency medical countermeasures enterprise (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGjRfPhFQY6Rg7F49c8FqP  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Public health emergency medical countermeasures enterprise.  |d Washington : National Academies Press, ©2010  |z 9780309150248  |w (OCoLC)646005428 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378620  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36615342 
938 |a Askews and Holts Library Services  |b ASKH  |n AH36559218 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3378620 
938 |a ebrary  |b EBRY  |n ebr10395834 
938 |a EBSCOhost  |b EBSC  |n 326069 
938 |a YBP Library Services  |b YANK  |n 3411421 
938 |a Internet Archive  |b INAR  |n publichealthemer0000unse 
994 |a 92  |b IZTAP